GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » Common Stock

Samsung BioLogics Co (XKRX:207940) Common Stock : ₩177,935 Mil (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Samsung BioLogics Co Common Stock?

Samsung BioLogics Co's quarterly common stock stayed the same from Mar. 2024 (₩177,935 Mil) to Jun. 2024 (₩177,935 Mil) and stayed the same from Jun. 2024 (₩177,935 Mil) to Sep. 2024 (₩177,935 Mil).

Samsung BioLogics Co's annual common stock increased from Dec. 2021 (₩165,413 Mil) to Dec. 2022 (₩177,935 Mil) but then stayed the same from Dec. 2022 (₩177,935 Mil) to Dec. 2023 (₩177,935 Mil).


Samsung BioLogics Co Common Stock Historical Data

The historical data trend for Samsung BioLogics Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung BioLogics Co Common Stock Chart

Samsung BioLogics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 165,412.50 165,412.50 165,412.50 177,935.00 177,935.00

Samsung BioLogics Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 177,935.00 177,935.00 177,935.00 177,935.00 177,935.00

Samsung BioLogics Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Samsung BioLogics Co Business Description

Traded in Other Exchanges
N/A
Address
125, Cheomdan-daero, Yeonsu-gu, Incheon, KOR
Founded in 2011, Samsung Biologics is a South Korean contract development and manufacturing organization with a global client base. Europe and the US contribute 90% of its total revenue. It provides end-to-end development and manufacturing services from cell line developments to final commercial manufacturing. As of 2023, Samsung Biologics had a total production capacity of 604,000 liters, one of the largest in the world. Its CDMO services account for 72.4% of its total revenue. The balance comes from subsidiary Samsung Bioepis, acquired in 2022. Samsung Bioepis is involved in developing and manufacturing biosimilars.

Samsung BioLogics Co Headlines

No Headlines